Sovran Advisors’s Clorox CLX Stock Holding History

Sovran Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,661	Closed	-$232K	–	499
2025 Q1	$232K	Buy	1,661 +18	+1%	+$2.75K	0.03%	426
2024 Q4	$261K	Buy	+1,643	New	+$269K	0.04%	362

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sovran Advisors's CLX Position: Q2 2025 in Review

Sovran Advisors sold out of Clorox (CLX) in Q2 2025, closing a stake of 1,661 shares — an estimated $232K sold.

Sovran Advisors first reported a position in CLX in Q4 2024 and held it in 2 quarters. The position peaked at $261K in Q4 2024. 1,126 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

Sovran Advisors reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
Sovran Advisors sold 1,661 Clorox shares in Q2 2025, an estimated $232K.
Sovran Advisors first reported a position in Clorox in Q4 2024 and held it in 2 quarters.
Sovran Advisors's Clorox position peaked at $261K in Q4 2024.
1,126 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on Sovran Advisors's 13F filing for Q2 2025, filed 10 Jul 2025.